Description
Sold as a lyophilized powder which must be reconstituted with bacteriostatic water.
Cagrilintide with Semaglutide is a combination of two peptide-based compounds primarily used for:
⚖️ Weight Loss and Appetite Suppression
Cagrilintide is an amylin analog that promotes satiety and delays gastric emptying, helping users feel full longer.
Semaglutide is a GLP-1 receptor agonist that also reduces appetite and lowers food intake, while helping regulate blood sugar levels.
Together, they have a synergistic effect on:
Reducing hunger
Controlling cravings
Promoting significant fat loss
💉 Potential Use in Obesity Treatment
This combination is being studied for its effectiveness in treating obesity and metabolic disorders without the need for surgery.
Early clinical trials show enhanced weight loss when used together compared to either compound alone.
⚠️ Important Notes
Investigational use: This combination is under clinical research and not yet widely approved for use.
Side effects may include nausea, constipation, or mild gastrointestinal discomfort.
Not recommended without medical supervision.
“For Research Use Only, Not for Human Consumption”
Reviews
There are no reviews yet.